FEBUXOSTAT

Generic: FEBUXOSTAT

Solco Healthcare US LLCManufacturer
ORALRoute
FEBUXOSTATActive Substance
2022-03-28Original Approval

FEBUXOSTAT is FDA application ANDA206266, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
ACUTE KIDNEY INJURY
636 reports
2
OFF LABEL USE
576 reports
3
DIARRHOEA
559 reports
4
ANAEMIA
511 reports
5
NAUSEA
504 reports
6
RENAL IMPAIRMENT
469 reports
7
PYREXIA
442 reports
8
DYSPNOEA
413 reports
9
RASH
409 reports
10
DRUG INEFFECTIVE
397 reports